Bernard J. Zovighian - May 30, 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CEO, Director
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: May 30, 2024
Transactions value $: -$755,539
Form type: 4
Date filed: 5/30/2024, 05:10 PM
Previous filing: May 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Sale	-$756K	-8.62K	-11.21%	$87.68	68.2K	May 30, 2024	Direct	F1
holding	EW	Common Stock						3.27K	May 30, 2024	401(k)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 29, 2024.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.